Similarly, KRT17 acts as a key epithelial activation marker prominently expressed during Th1-mediated inflammatory conditions such as psoriasis, but is notably absent in predominantly Th2-driven disorders like AD (94, 113, 114). This evidence concerns the gene KRT17 and psoriasis.